[1]范维肖,刁艳君,马越云,等.超速离心法与QIAGEN膜亲和柱法提取前列腺癌细胞培养上清外泌体的方法学比较[J].现代检验医学杂志,2019,34(03):6-9.[doi:10.3969/j.issn.1671-7414.2019.03.002]
 FAN Wei-xiao,DIAO Yan-jun,MA Yue-yun,et al.Comparison of Ultracentrifugation and Membrane Based-Affinity ColumnMethods in Exosome Isolation from Supernatants of Prostate Cancer Cells[J].Journal of Modern Laboratory Medicine,2019,34(03):6-9.[doi:10.3969/j.issn.1671-7414.2019.03.002]
点击复制

超速离心法与QIAGEN膜亲和柱法提取前列腺癌细胞培养上清外泌体的方法学比较()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第34卷
期数:
2019年03期
页码:
6-9
栏目:
论著
出版日期:
2019-06-20

文章信息/Info

Title:
Comparison of Ultracentrifugation and Membrane Based-Affinity ColumnMethods in Exosome Isolation from Supernatants of Prostate Cancer Cells
文章编号:
1671-7414(2019)03-006-04
作者:
范维肖刁艳君马越云郝晓柯
(空军军医大学西京医院检验科,西安 710032)
Author(s):
FAN Wei-xiaoDIAO Yan-junMA Yue-yunHAO Xiao-ke
(Department of LaboratoryMedicine,Xijing Hospital Affiliated to Air Force Medical University,Xi'an 710032,China)
关键词:
前列腺癌 外泌体 超速离心法 膜亲和柱法
分类号:
R737.25; R730.43
DOI:
10.3969/j.issn.1671-7414.2019.03.002
文献标志码:
A
摘要:
目的 对超速离心法与QIAGEN膜亲和柱法提取前列腺癌细胞上清外泌体优缺点进行比较,为外泌体相关基础实验研究及临床检测提供方法学参考。方法 收集前列腺癌细胞上清分别用两种方法提取外泌体,进行电镜鉴定、BCA定量测定蛋白浓度、Western blot检测标志蛋白以及Zetaview颗粒粒径、浓度及电势分析,比较两种方法提取外泌体的优缺点。结果 电镜下两种方法均可观察到具有膜结构的典型的类似于茶托状结构的外泌体,但膜亲和柱法提取外泌体背景中有类似蛋白聚合物等杂质的存在,超离背景纯净,每个视野下的外泌体数量要明显多于QIAGEN膜亲和柱法; Western blot测定标志蛋白,根据BCA定量同等上样量超速离心法可观察到明显的β-actin,ALIX,CD63以及EGFR条带,而QIAGEN膜亲和柱法仅可观察到β-actin,ALIX以及EGFR条带,但均较超速离心法条带弱; Zetaview粒径分析,超速离心法粒径分布峰值为116 nm,膜亲和柱法提取外泌体分布峰值为122 nm,均符合外泌体的粒径分布范围; 电势分析两者均为负值,符合外泌体的电势分布; 而颗粒数与蛋白浓度比值超速离心法提取外泌体要高于QIAGEN膜亲和柱法(t=13.47,P<0.01)。结论 超速离心法与膜亲和柱法均可以从细胞上清中提取外泌体,超速离心法步骤繁琐,时间较长,但外泌体纯度高,杂质少,BCA蛋白定量与实际所含外泌体蛋白量基本一致; QIAGEN膜亲和柱法方法简单,可快速从细胞上清中提取到外泌体,但纯度不及超速离心法,BCA蛋白定量比实际所含外泌体蛋白量要高,超速离心法适用于外泌体的各方面研究,而QIAGEN膜亲和柱法由于有杂蛋白的污染,因此更适用于外泌体核酸分析相关研究。
Abstract:
Objective To compare the advantages and disadvantages of ultracentrifugation(UC)and membrane-based affinity column in isolation of exosomes from prostate cancer cell supernatants.Methods Exosomes were isolated by these two methods from LNCaP-AI+F prostate cancer cells,the typical structure of exosomes was observed and captured in electron microscope.BCA assay was used to measure the protein concentration of exosomes,western blot were used to identify the proteins in exosomes and zetaview wereused to detect the diameter,particle concentration and zeta potential of exosomes.Results Typical structure of exosomes isolated by two methods could be all observed by electron microscope,while there were some aggregates impurities in the background of exosomes isolated by membrane-based affinity column.There were little impurities in the background of exosomes isolated by UC and more exosomes in a single eyeshot.Western blot results showed thatexosomes isolated by UC had obvious β-actin,ALIX,CD63 and EGFR bands whileexosomes isolated by membrane-based affinity column only displayed β-actin,ALIX and EGFR bands and were weaker than exosomes isolated by UC.Zetaview particle size analysis showed that the peak number of exosomes isolated by UC and membrane-based affinity column were respectively 116 nm and 122 nm and were both inline with the range of exosome diameter distribution.Zeta Potential of exosomes isolated by these two methods were both negative which accords with the previous reports.The ratio of particle number to protein concentration by UC was higher than that of membrane-based affinity column method(t=13.47,P<0.05).Conclusion Both UC and membrane-based affinity column can extract exosomes from cell supernatants.The UC method is cumbersome and time-consuming,but the exosomes are high in purity and the BCA protein quantification represents the actual exosomes proteins.Membrane-based affinity column method can quickly extract exosomes from cell supernatants,but the purity is lowerthan ultracentrifugation because of the existence of aggregates proteins.UC issuitable for all aspects of exosome research and membrane-based affinity column is more suitable for exosome nucleic acid analysis because of the contamination of heterologous proteins.

参考文献/References:

[1] HEIJNEN H F,SCHIEL A E,FIJNHEER R,et al.Activated platelets release two types of membrane vesicles:microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules[J].Blood 1999,94(11):3791-3799.
[2] MILANE L,SINGH A,MATTHEOLABAKIS G,et al.Exosome mediated communication within the tumor microenvironment[J].Journal of Controlled Release,2015,219:278-294.
[3] STEINBICHLER T B,DUDAS J,RIECHELMANN H,et al.The role of exosomes incancer metastasis[J].Semin Cancer Biol,2017,44:170-181.
[4] CHI K R.The tumour trail left in blood[J].Nature,2016,532(7598):269-271.
[5] CHEN Gang,HUANG A C,ZHANG Wei,et al.Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response[J].Nature,2018,560(7718):382-386.
[6] MELO S A,LUECKE L B,KAHLERT C,et al.Gly-pican-1 identifies cancer exosomes and detects early pancreatic cancer[J].Nature,2015,523(7559):177-182.
[7] LOBB R J,BECKER M,WEN S W,et al.Optimized exosome isolation protocolfor cell culture supernatant and human plasma[J].J Extracell Vesicles,2015,4:27031.
[8] 蒲双双.外泌体的提取、鉴定和保存方法研究进展[J].现代检验医学杂志,2018,33(5):157-160. PU Shuangshuang.Research progress in isolation,id-entificaion andpreservation of exosomes[J].J Mod Lab Med,2018,33(5),157-160.
[9] THERY C,AMIGORENA S,RAPOSO G,et al.Isolation and characterization ofexosomes from cell culture supernatants and biological fluids[J].Curr ProtocCell Biol,2006,Chapter 3:Unit 3.22.1-3.22.29.
[10] HELWA I,CAI J,DREWRY M D,et al.A comparative study of serumexosome isolation using differential ultracentrifugation and three commercial reagents[J].PLoS One,2017,12(1):e0170628.
[11] DEREGIBUS M C,FIGLIOLINI F,D'ANTICO S,et al.Charge-based precipitation of extracellular vesicles[J].Int J Mol Med,2016,38(5):1359-1366.
[12] BHATTACHARJEE S.DLS and zeta potentialwha-t they are and what they arenot[J].J Control Release,2016,235:337-351.
[13] WEBBEER J,CLAYTON A.How pure are your ve-sicles?[J].J Extracell Vesicles,2013,2:19861.
[14] PEINADO H,ALECKOVIC M,LAVOTSHKIN S,et al.Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET[J].Nat Med,2012,18(6):883-891.
[15] FANG Tian,L(¨overU)Hongwei,L(¨overU)Guishuai,et al.Tu-mor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer[J].Nat Commun,2018,9(1):191.
[16] DE RITA R M,ZERLANKO B,SINGH A,et al.c-Src,insulin-like growth factor I receptor,G-protein-coupled receptor kinases and focal adhesion kinaseare enriched into prostate cancer cell exosomes[J].J Cell Biochem,2017,118(1):66-73.
[17] BIJNSDORP I V,GELDOF A A,LAVAEI M.Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients[J].J Extracell Vesicles,2013,2:22097.
[18] HUANG Xiaoyi,YUAN Tiezheng,LIANG Meihua,et al.Exosomal miR-1290 andmiR-375 as prognostic markers in castration-resistant prostate cancer[J].Eur Urol,2015,67(1):33-41.
[19] LI Zhuo,MA Yueyun,WANG Juan,et al.Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients[J].Onco Targets Ther,2016,9(Issue 1):139-148.

相似文献/References:

[1]廖洪利,米叶赛尔·阿不都拉.粘着斑激酶在前列腺癌中表达的研究[J].现代检验医学杂志,2016,31(05):132.[doi:10.3969/j.issn.1671-7414.2016.05.038]
 LIAO Hong-li,MIYESAIER·Abdula.Research on Expression of FAK in Prostate Carcinoma[J].Journal of Modern Laboratory Medicine,2016,31(03):132.[doi:10.3969/j.issn.1671-7414.2016.05.038]
[2]李腾达,刘 鹏,龙曙萍,等.隐球菌脑膜炎患者血清外泌体CD93表达增高及意义[J].现代检验医学杂志,2017,32(06):23.[doi:10.3969/j.issn.1671-7414.2017.06.001]
 LI Teng-da,LIU Peng,LONG Shu-ping,et al.Elevated Expression of CD93 in Serous Exosomes from Patients with Cryptococcal Meningitis and Its Significance[J].Journal of Modern Laboratory Medicine,2017,32(03):23.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[3]李腾达,刘 鹏,龙曙萍,等.表面增强拉曼光谱技术检测隐球菌脑膜炎患者血清中CD93+外泌体及其意义[J].现代检验医学杂志,2018,33(04):4.[doi:10.3969/j.issn.1671-7414.2018.04.002]
 LI Teng-da,LIU Peng,LONG Shu-ping,et al.Detection of Serum CD93+Exosomes in Patients with Cryptococcal Meningitis by Surface-Enhanced Raman Scattering Technology and Its Significance[J].Journal of Modern Laboratory Medicine,2018,33(03):4.[doi:10.3969/j.issn.1671-7414.2018.04.002]
[4]李腾达,龙曙萍,黄元兰,等.自身免疫性胰腺炎患者血清外泌体中CD69表达升高及意义[J].现代检验医学杂志,2018,33(02):8.[doi:10.3969/j.issn.1671-7414.2018.02.001]
 LI Teng-da,LONG Shu-ping,HUANG Yuan-lan,et al.Elevated Expression of CD69 in Serum Exosomes from Patients with Autoimmune Pancreatitis and Its Significance[J].Journal of Modern Laboratory Medicine,2018,33(03):8.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[5]潘良明,沈菲菲,马晓英,等.血清前列腺健康指数对 tPSA灰区前列腺癌患者的诊断价值探讨[J].现代检验医学杂志,2021,36(01):72.[doi:10.3969/j.issn.1671-7414.2021.01.019]
 PAN Liang-ming,SHEN Fei-fei,MA Xiao-ying,et al.Diagnostic Value of Serum Prostate Health Index in Prostate Cancer Patients with PSA Gray Area[J].Journal of Modern Laboratory Medicine,2021,36(03):72.[doi:10.3969/j.issn.1671-7414.2021.01.019]
[6]何 跃,梁 晶,文礼红,等.前列腺癌患者血清IL-17和IL-35水平表达与临床病理特征以及预后的关系研究[J].现代检验医学杂志,2021,36(04):96.[doi:10.3969/j.issn.1671-7414.2021.04.020]
 HE Yue,LIANG Jing,WEN Li-hong,et al.Study on the Relationship between Serum IL-17, IL-35 Levels andClinicopathological Features and Prognosis in Patients with Prostate Cancer[J].Journal of Modern Laboratory Medicine,2021,36(03):96.[doi:10.3969/j.issn.1671-7414.2021.04.020]
[7]荣 蓉a,古 颖a,高 翔a,等.前列腺癌组织肝激酶B1,Rab鸟嘌呤核苷酸交换因子-5mRNA表达水平与临床病理特征和预后的相关性研究[J].现代检验医学杂志,2021,36(06):1.[doi:10.3969/j.issn.1671-7414.2021.06.001]
 RONG Rong,GU Ying,GAO Xiang,et al.Correlation between the Expression Levels of Liver Kinase B1, Rab Guanine Nucleotide Exchange Factor-5 mRNA in Prostate Cancer Tissues and Its Clinicopathological Characteristics and Prognosis[J].Journal of Modern Laboratory Medicine,2021,36(03):1.[doi:10.3969/j.issn.1671-7414.2021.06.001]
[8]张士保,朱斐煜,谢瑞玉,等.CircRNA-100395 基因通过启动子区甲基化调控miRNA-136-5p/Smad3 轴促进前列腺癌细胞增殖及侵袭的机制研究[J].现代检验医学杂志,2022,37(05):44.[doi:10.3969/j.issn.1671-7414.2022.05.010]
 ZHANG Shi-bao,ZHU Fei-yu,XIE Rui-yu,et al.Mechanism of CircRNA-100395 Promoter Methylation Promoting Prostate Cancer Cells Proliferation and Invasion by Regulating miRNA-136-5p/Smad3 Axis[J].Journal of Modern Laboratory Medicine,2022,37(03):44.[doi:10.3969/j.issn.1671-7414.2022.05.010]
[9]阴铭迪,李 林.前列腺癌实验室诊断的最新进展[J].现代检验医学杂志,2022,37(05):194.[doi:10.3969/j.issn.1671-7414.2022.05.039]
 YIN Ming-di,LI Lin.Recent Advances in Laboratory Diagnosis of Prostate Cancer[J].Journal of Modern Laboratory Medicine,2022,37(03):194.[doi:10.3969/j.issn.1671-7414.2022.05.039]
[10]郑江婷,寸淑娥,尹 冶,等.长链非编码RNA 在前列腺癌治疗抵抗中作用机制的研究进展[J].现代检验医学杂志,2023,38(01):199.[doi:10.3969/j.issn.1671-7414.2023.01.038]
 ZHENG Jiang-ting,CUN Shu-e,YIN Ye,et al.Research Progress of Long Non-coding RNA in the Therapeutic Resistance of Prostate Cancer[J].Journal of Modern Laboratory Medicine,2023,38(03):199.[doi:10.3969/j.issn.1671-7414.2023.01.038]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81872347)。 作者简介:范维肖(1993-),男,硕士,主要从事前列腺癌外泌体的研究,E-mail:1325899014@qq.com。 通讯作者:郝晓柯,男,主任医师,博士生导师,主要从事前列腺癌分子诊断研究,E-mail: haoxkg@fmmu.edu.cn。 收稿日期:2019-04-03 修回日期:2019-04-16
更新日期/Last Update: 2019-06-20